Trials / Unknown
UnknownNCT00520377
Pilot Study on Safety and Efficacy of MD05 in Comparison With Beta-TCP in Patients Undergoing Sinus Floor Augmentation
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Scil Technology GmbH · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is the area of newly formed bone (%) as assessed by histomorphometry with either MD05 or beta-TCP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MD05 | recombinant human GDF-5 coated onto beta-tricalcium phosphate |
| DEVICE | Beta-TCP and autologous bone | beta-tricalcium phosphate and autologous bone |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2007-12-01
- Completion
- 2008-05-01
- First posted
- 2007-08-24
- Last updated
- 2008-04-23
Locations
9 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00520377. Inclusion in this directory is not an endorsement.